Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 322 followers
Latest posts
Last updated about 1 hour ago
Fired NIH institute director sues Trump health officials, seeks reinstatement and backpay
about 1 hour ago
The former director of the National Institutes of Health’s National Institute of...
CMR Surgical grabs FDA clearance for upgraded Versius Plus robot
about 2 hours ago
After claiming its first U.S. robotic surgery clearance late last year, CMR...
Norgine gets in on Vir's hepatitis D program with €550 European licensing pact
about 2 hours ago
Norgine secured an exclusive license to commercialize Vir Biotechnology's combo hepatitis D...
Oncology biotech Mythic and former fundraising heavyweight Areteia reach end of road
about 2 hours ago
After layoffs this fall, Mythic Therapeutics is winding down, while asthma-focused Areteia...
Medline makes Nasdaq debut, raising $6.26B in year’s largest IPO
about 3 hours ago
After operating outside the spotlight for years, Medline is taking center stage...
Medtronic rolls out new peripheral thrombectomy system while making advances in brain bleeds
about 5 hours ago
The Liberant aspiration catheters are designed to snake into blocked arteries and...
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B
about 6 hours ago
Bristol Myers Squibb has become the latest Big Pharma to tie up...
Addition Tx does the math and emerges from stealth with $100M, biotech vets on exec team
about 7 hours ago
University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” PRINT technology...
Nektar claims phase 2 alopecia success after excluding patients who ‘should never have been enrolled’
about 21 hours ago
Nektar Therapeutics is planning to bring its interleukin-2-targeting drug candidate into a...
Siemens Healthineers taps ALZpath for Alzheimer’s blood test biomarker
about 24 hours ago
ALZpath licensed out its pTau-217 antibody, currently under development, which Siemens Healthineers...
Ramaswamy-backed Ambros Therapeutics launches with $125M to develop pain drug
1 day ago
Vivek Ramaswamy has found time out of his campaign for governor of...
FDA opens door to massive real-world datasets in medical device submissions
1 day ago
The agency said the policy change aims to enable the use of...